Analyst Profile

Followed by 312 followers
.
Mara Goldstein

Mara Goldstein

Mizuho Securities
Wall Street Analyst
#4,087 out of 8,141 Wall Street Analysts
#10,077 out of 24,284 experts

Success Rate

36%
115 out of 321 transactions made a profit

Average Return

+0.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Mara Goldstein's trades since 2013 and holding each position for 1 Year would result in 35.83% of your transactions generating a profit, with an average return of 0.6% per rating.

Stock Rating Distribution

1KRatings
75.11% Buy
24.22% Hold
0.67% Sell
Distribution of Mara Goldstein's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
United KingdomUK Market

Best Rating

Stock:
Forty Seven
(FTSV)
Rating:Buy
Date:Nov 06, 2019 - Mar 04, 2020
Return:+800.00%
The most profitable rating made by Mara Goldstein

Mara Goldstein's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
DNDNQ
Dendreon Corp
Aug 09, 2013
Hold
Reiterated
3Ratings
0.00%
Statera BioPharma
Jan 24, 2014
Hold
Downgraded
$2.00
(1539.34% Upside)
2Ratings
0.00%
SELLAS Life Sciences Group
Dec 08, 2015
Hold
Upgraded
$2.00
(-15.97% Downside)
8Ratings
0.00%
NightHawk Biosciences
Apr 07, 2016
Buy
Reiterated
9Ratings
0.00%
Agile Therapeutics
May 16, 2016
Buy
Reiterated
1Ratings
0.00%
RLYP
Relypsa Inc
Aug 04, 2016
Hold
Reiterated
13Ratings
0.00%
Imunon
Oct 07, 2016
Buy
Reiterated
$7.00
(382.73% Upside)
2Ratings
0.00%
Synlogic
Apr 13, 2017
Hold
Reiterated
$14.00
(2180.50% Upside)
4Ratings
0.00%
Arcturus Therapeutics
Apr 13, 2017
Hold
Reiterated
$7.00
(-57.52% Downside)
8Ratings
0.00%
Outlook Therapeutics
Apr 13, 2017
Buy
Reiterated
$15.00
(1328.57% Upside)
1Ratings
0.00%
List of latest recommendations made by Mara Goldstein. Click to expand and see Mara Goldstein's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >